Vimarsana
Biggest News Aggregation in the World

Page 4 - Exp Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exp Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exp Med Today - Breaking & Trending Today

What's the difference between HeLa and HeLa S3 cells? Part III: Theodore "Ted" Puck, PhD, and the first clonal isolation of human tumor cells - Vimarsana News

What's the difference between HeLa and HeLa S3 cells? Part III: Theodore "Ted" Puck, PhD, and the first clonal isolation of human tumor cells

By terrasig on March 16, 2010. This post is the third in a series on the origin and history of HeLa S3 cells. The first post details how I came about to ask this question when launching my independent research laboratory. The second post details the life and careers of the legendary physician-scientist pioneer, Dr. Florence Rena Sabin. Today, we take up a discussion where we will finally learn the origin of HeLa S3 cells, complete with original literature citations. A recap We left our previous discussion with the final and still-productive years of Dr. Florence Rena Sabin...

COMMENTARY: From hope to reality: The promise of the Influenza Vaccines R&D Roadmap - Vimarsana News

COMMENTARY: From hope to reality: The promise of the Influenza Vaccines R&D Roadmap

SteveAllenPhoto / iStock Note: The views expressed in this commentary reflect the opinions of the authors and do not necessarily represent the policies or official positions of their organizations. Since the COVID-19 pandemic began roughly a year ago, public health officials have recorded more than 2 million deaths and almost 100 million infections from the SARS-CoV-2 virus, with the actual number likely substantially higher. Healthcare systems have been overwhelmed with caring for those suffering serious consequences of infection, straining the capacity of even the most sophisticated hospita...

Source: umn.edu
Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference - Vimarsana News

Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference

Share this article Share this article GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented clinical and preclinical updates at the 39th Annual J.P. Morgan Healthcare Conference.  Helen Sabzevari, PhD, President and CEO of Precigen, presented a summary of 2020 clinical achievements and set forth Precigen's clinical goals for 2021. In addition to reviewing the latest clinical updates for Precigen's PRGN-3005 UltraCAR-T, ...

Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G - Vimarsana News

Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G

Posted December 16th, 2020 for Novartis Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients’ quality of life 1–3 C3 glomerulopathy (C3G) is a rare renal disease, affecting young patients with a poor prognosis and significant unmet need 4-5 With potential to be the first oral treatment for a range of complement-driven diseases, complement factor B inhibitor iptacopan targets the underlying cause of these conditions through its action on the complement system’s alternative pathway 6,7 ...

Pandemic meets epidemic: COVID-19 and neurodegenerative diseases - Vimarsana News

Pandemic meets epidemic: COVID-19 and neurodegenerative diseases

Science Communication Opinion Share Post In this opinion piece, Andrei Surguchov, Professor of Neurology at University of Kansas Medical Center and Chief Editor of Biochemistry Research International, reflects on the impact the COVID-19 has had on the epidemic of neurodegenerative diseases and dementia. Lack of an active treatment strategy and vaccine makes SARS-CoV-2 infection an immense threat to humankind. The COVID-19 pandemic arrived when the world was already facing other rising health problems, one of the most serious of which is the epidemic of neurodegenerative diseases and dementia....